Evommune, Inc. Common Stock (EVMN)

Stock-Based Compensation

$4.60M

Quarterly · Period ending: · USD

EVMN logo

EVMN Stock-Based Compensation

Latest reported$4.60M
EVMN Quarterly Stock-Based Comp ($0.00 → $4.60M)
High-resolution chart · PNG

EVMN stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
4,598,000
3,454,000
4,196,000
560,000
0
0
494,000
402,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.